BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • BioTech Events
  • BioTech Company Directory
  • Contact Us
Archives
  • August 2023
  • July 2023
  • May 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2017
  • March 2014
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • BioTech Events
  • BioTech Company Directory
  • Contact Us
Subscribe

Browsing Category

Biotech News

44 posts

Latest Biotech Company News & Drug Development FDA Approval Updates

Welcome to the pulse of the biotechnology world at BioTech HealthX! In this category, we dive deep into the latest and freshest developments from the most innovative biotech companies globally. Here, you can stay updated on the breakthroughs and progress that are shaping the future of healthcare from clinical testing to the top stories as they develop our team covers the latest from the FDA agency decisions as they are approved to evidence and continuing scientific based trials.

Key features:

  1. Up-to-the-minute Reports: Get instant notifications about the newest advancements, mergers, and acquisitions in the biotech sector, ensuring you never miss a beat.
  2. Drug Development Insights: From initial research phases to clinical trials, track the journey of prospective drugs as they navigate the intricate path to potential FDA approval.
  3. FDA Approval Announcements: Be the first to know which novel treatments have been granted the green light by the FDA, transforming patient care possibilities and market dynamics.
  4. In-depth Analyses: Apart from just news, we offer expert commentary and analyses on what these developments mean for the industry, investors, and most importantly, patients.
  5. Global Perspective: The biotech landscape is vast and diverse. We ensure coverage from startups to big pharma, from domestic news to global phenomena, giving you a comprehensive understanding of the sector.
Welcome To BioTech Health X

Biotech NewsWelcome To BioTech Health X

  • BioTech Health X
  • May 26, 2023
The New Leader in BioTech News, BioTech Stock Information & BioTech Industry Analysis BioTech Health X delivers the…
0 Shares
0
0
0
0
0
0
0
Recent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data

Biotech NewsRecent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data

  • BioTech Health X
  • May 9, 2023
A recent report published by the American Association for Cancer Research titled Subgroup Analyses in Oncology Trials: Regulatory…
0 Shares
0
0
0
0
0
0
0
Virios-Therapeutics-Stock-Plunges-70-on-Fibromyalgia-Clinical-Trial-Failure-Results

Biotech NewsVirios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results

  • BioTech Health X
  • September 19, 2022
In a shocking failure, Virios Therapeutics announced this morning pre-market that topline results from its FORTRESS (Fibromyalgia Outcome…
0 Shares
0
0
0
0
0
0
0
CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022

Biotech NewsCEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022

  • BioTech Health X
  • September 10, 2022
CEL-SCI recently presented its Phase 3 data at ESMO 2022, which revealed that Neoadjuvant Multikine achieved groundbreaking tumor…
0 Shares
0
0
0
0
0
0
0
Mayo-Clinic-Gene-Accelerator

Biotech NewsMayo Clinic, Hibiscus BioVentures, and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator

  • BioTech Health X
  • August 31, 2022
Mayo Clinic, Hibiscus BioVentures (Hibiscus), and Innoforce have announced the formation of Mayflower BioVentures, a cell and gene…
0 Shares
0
0
0
0
0
0
0
Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial

Biotech NewsKrystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial

  • BioTech Health X
  • August 1, 2022
Leader in redosable gene therapy Krystal Biotech, Inc. (NASDAQ: KRYS) announced today the United States Food and Drug…
0 Shares
0
0
0
0
0
0
0
ImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug

Biotech NewsImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug

  • BioTech Health X
  • July 28, 2022
In breaking news, clinical-stage biotechnology company ImmunityBio, Inc. (NASDAQ: IBRX) has announced acceptance by the FDA review of…
0 Shares
0
0
0
0
0
0
0
Brickell Biotech Regains Nasdaq Compliance Meeting Minimum Bid Price Requirement

Biotech NewsBrickell Biotech Regains Nasdaq Compliance Meeting Minimum Bid Price Requirement

  • BioTech Health X
  • July 20, 2022
Clinical-stage pharmaceutical company Brickell Biotech, Inc. (Nasdaq: BBI) announced that the company has received formal notice from The…
0 Shares
0
0
0
0
0
0
0
Merck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial

Biotech NewsMerck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial

  • BioTech Health X
  • July 20, 2022
Today Merck & Co. (NYSE: MRK) announced that Keytruda has failed the Phase 3 clinical trial KEYNOTE-412 evaluating…
0 Shares
0
0
0
0
0
0
0
Ocugen Announces FDA Clinical Hold Removal for Phase 2:3 COVAXIN BBV152 Clinical Trial

Biotech NewsOcugen Announces FDA Clinical Hold Removal for Phase 2/3 COVAXIN (BBV152) Clinical Trial

  • BioTech Health X
  • May 23, 2022
Biotechnology company Ocugen, Inc. (NASDAQ: OCGN) announced today that the U.S. Food and Drug Administration (FDA) has removed…
0 Shares
0
0
0
0
0
0
0
BenchSci Expands Advisory Board with New Pharma R&D Leaders

Biotech NewsBenchSci Expands Advisory Board with New Pharma R&D Leaders

  • Jak Thomson
  • April 21, 2022
BenchSci has welcomed three new members to its advisory board from the pharmacology sector. Steve Hitchcock of Takeda…
0 Shares
0
0
0
0
0
0
0
EF Hutton Initiates Coverage of Cel-Sci CVM with 17 Price Target Ahead of Rumored News

Biotech NewsEF Hutton Initiates Coverage of Cel-Sci (CVM) with $17 Price Target Ahead of Rumored News

  • BioTech Health X
  • April 7, 2022
Tim Moore, CFA an Analyst at EF Hutton has recently published a report citing the opportunities for growth…
0 Shares
0
0
0
0
0
0
0
Legend Biotech Appoints Dr Guowei Fang Head of Global Research and Early Development

Biotech NewsLegend Biotech Appoints Dr. Guowei Fang As Head of Global Research and Early Development

  • BioTech Health X
  • April 1, 2022
Global biotechnology company Legend Biotech Corporation (NASDAQ: LEGN) announced today that Guowei Fang, Ph.D. will take over as…
0 Shares
0
0
0
0
0
0
0
2seventy-bio-Secure-170-Million-Extending-Cash-Runway-Into-2025

Biotech News2seventy bio Secure $170 Million Extending Cash Runway Into 2025

  • BioTech Health X
  • March 16, 2022
2seventy bio (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, today announced that it has agreed to sell…
0 Shares
0
0
0
0
0
0
0
Inhibikase-Therapeutics-Present-Phase-1-1b-Trial-Results-ADPD-Alzheimers-Parkinsons-Diseases-Conference

Biotech NewsInhibikase Therapeutics To Present Phase 1/1b Trial Results at AD/PD Alzheimer’s & Parkinson’s Diseases Conference

  • BioTech Health X
  • March 8, 2022
Clinical-stage pharmaceutical company Inhibikase Therapeutics, Inc. (Nasdaq: IKT) recently announced that President and CEO Dr. Milton Werner, Ph.D. will be…
0 Shares
0
0
0
0
0
0
0
Celyad-Oncology-Pauses-CYAD-101-002-Keynote-B79-Phase-1-Trial-After-2-Deaths-Reported

Biotech NewsCelyad Oncology Pauses CYAD-101-002 (Keynote-B79) Phase 1 Trial After 2 Deaths Reported

  • BioTech Health X
  • February 28, 2022
Clinical-stage biotechnology company Celyad Oncology (NASDAQ: CYAD) recently announced that the company has voluntarily paused the CYAD-101-002 (KEYNOTE-B79)…
0 Shares
0
0
0
0
0
0
0
Cellarity-Expands-Leadership-Team-to-Continue-Evolution-of-Breakthrough-Platform-to-Encode-Biology-and-Purposefully-Create-New-DrugsCellarity-Expands-Leadership-Team

Biotech NewsCellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs

  • BioTech Health X
  • February 10, 2022
With the appointments of these experts, the firm has added to its industry knowledge, including Chief Scientific Officer…
0 Shares
0
0
0
0
0
0
0
Nasdaq Biotechnology Index Adds Quantum-Si Nasdaq QSI Life Sciences Company

Biotech NewsNasdaq Biotechnology Index Adds Quantum-Si (Nasdaq: QSI) Life Sciences Company

  • BioTech Health X
  • December 14, 2021
Quantum-Si (Nasdaq: QSI), a life science instrumentation firm commercializing a distinctive protein sequencing technology, has been added to…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Alterome Therapeutics Strengthens Leadership Team with Appointment of Renowned Oncologist Dr. Andrew S. Chi as Chief Medical Officer
  • Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • 11/19/21
  • Welcome To BioTech Health X
  • Recent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data
Recent Comments
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • August 23, 2023
    Alterome Therapeutics Strengthens Leadership Team with Appointment of Renowned Oncologist Dr. Andrew S. Chi as Chief Medical Officer
    • July 14, 2023
    Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
    Exclusive Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
    • May 30, 2023
    11/19/21
    • May 26, 2023
    Welcome To BioTech Health X
    Welcome To BioTech Health X
    • May 9, 2023
    Recent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data
    Recent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data
Recent Posts
  • What is Biotechnology: Types, Examples and Applications
    • June 24, 2022
  • BioTech Health X CEO Series Virios Therapeutics Greg Duncan
    BioTech Health X CEO Series: Virios Therapeutics Greg Duncan
    • February 1, 2022
  • Sigilon Therapeutics Provides Update on Strategic Reprioritization
    Sigilon Therapeutics Provides Update on Strategic Reprioritization
    • December 13, 2021
Categories
  • BioTech CEO Interviews (4)
  • Biotech Info (1)
  • Biotech News (44)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • Our Contributors
  • List of Modern Life Science Technologies
  • Contact Us

Subscribe to
Our Updates

Back to top